Literature DB >> 6099980

Pharmacokinetics of chloroquine in renal insufficiency.

L A Salako, O Walker, A O Iyun.   

Abstract

The pharmacokinetics of chloroquine and its desethyl metabolite were studied in six patients with chronic renal failure and compared with a control group of twelve patients with normal renal function. Chloroquine was given as a single oral dose of 600 mg and blood levels monitored for 144 h. Plasma chloroquine concentrations were determined using an HPLC method. The plasma half-life of chloroquine was significantly higher in renal patients than in controls. This finding suggests that extra caution should be exercised when prescribing chloroquine for prolonged use in patients with renal insufficiency.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6099980

Source DB:  PubMed          Journal:  Afr J Med Med Sci        ISSN: 0309-3913


  11 in total

1.  Molecular mechanism of renal tubular secretion of the antimalarial drug chloroquine.

Authors:  Fabian Müller; Jörg König; Hartmut Glaeser; Ingrid Schmidt; Oliver Zolk; Martin F Fromm; Renke Maas
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

Review 2.  Drug treatment and prevention of malaria.

Authors:  N J White
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 3.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

Review 4.  Treatment of malaria--1990.

Authors:  D M Panisko; J S Keystone
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

Review 5.  Antimalarial drug toxicity: a review.

Authors:  W Robert J Taylor; Nicholas J White
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 6.  Malaria prophylaxis in patients with renal impairment: a review.

Authors:  Sabine Amet; Sarah Zimner-Rapuch; Vincent Launay-Vacher; Nicolas Janus; Gilbert Deray
Journal:  Drug Saf       Date:  2013-02       Impact factor: 5.606

Review 7.  Antimalarial drugs. An update.

Authors:  D C Warhurst
Journal:  Drugs       Date:  1987-01       Impact factor: 9.546

8.  Single dose disposition of chloroquine in kwashiorkor and normal children--evidence for decreased absorption in kwashiorkor.

Authors:  O Walker; A H Dawodu; L A Salako; G Alván; A O Johnson
Journal:  Br J Clin Pharmacol       Date:  1987-04       Impact factor: 4.335

Review 9.  FIRST REPORTS OF CLINICAL PHARMACOKINETICS IN NIGERIA.

Authors:  O S Michael
Journal:  Ann Ib Postgrad Med       Date:  2015-06

Review 10.  Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19.

Authors:  Zi-Ning Lei; Zhuo-Xun Wu; Shaowei Dong; Dong-Hua Yang; Litu Zhang; Zunfu Ke; Chang Zou; Zhe-Sheng Chen
Journal:  Pharmacol Ther       Date:  2020-09-08       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.